242 related articles for article (PubMed ID: 24932684)
21. Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress.
Koga K; Kenessey A; Powell SR; Sison CP; Miller EJ; Ojamaa K
Antioxid Redox Signal; 2011 Apr; 14(7):1191-202. PubMed ID: 20831446
[TBL] [Abstract][Full Text] [Related]
22. MIF homolog d-dopachrome tautomerase (D-DT/MIF-2) does not inhibit accumulation and toxicity of misfolded SOD1.
Alaskarov A; Barel S; Bakavayev S; Kahn J; Israelson A
Sci Rep; 2022 Jun; 12(1):9570. PubMed ID: 35688953
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological significance of macrophage migration inhibitory factor and its relation with p53 in gastric cancer.
Nabizadeh Marvast M; Sima HR; Ghaffarzadehgan K; Taghizadeh Kermani A; Norouzi N
J Gastrointest Cancer; 2011 Mar; 42(1):5-10. PubMed ID: 20922580
[TBL] [Abstract][Full Text] [Related]
24. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.
Xia W; Zhang F; Xie C; Jiang M; Hou M
Stem Cell Res Ther; 2015 Apr; 6(1):82. PubMed ID: 25896286
[TBL] [Abstract][Full Text] [Related]
25. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
26. Dissociation of MIF-rpS3 complex and sequential NF-κB activation is involved in IR-induced metastatic conversion of NSCLC.
Youn H; Son B; Kim W; Jun SY; Lee JS; Lee JM; Kang C; Kim J; Youn B
J Cell Biochem; 2015 Nov; 116(11):2504-16. PubMed ID: 25900216
[TBL] [Abstract][Full Text] [Related]
27. Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells.
Xiao DZ; Dai B; Chen J; Luo Q; Liu XY; Lin QX; Li XH; Huang W; Yu XY
Cell Prolif; 2011 Dec; 44(6):582-90. PubMed ID: 21991924
[TBL] [Abstract][Full Text] [Related]
28. MIF Maintains the Tumorigenic Capacity of Brain Tumor-Initiating Cells by Directly Inhibiting p53.
Fukaya R; Ohta S; Yaguchi T; Matsuzaki Y; Sugihara E; Okano H; Saya H; Kawakami Y; Kawase T; Yoshida K; Toda M
Cancer Res; 2016 May; 76(9):2813-23. PubMed ID: 26980763
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of macrophage activation by the MIF cytokine superfamily members MIF and MIF-2 in adipose tissue during endotoxemia.
Kim BS; Tilstam PV; Arnke K; Leng L; Ruhl T; Piecychna M; Schulte W; Sauler M; Frueh FS; Storti G; Lindenblatt N; Giovanoli P; Pallua N; Bernhagen J; Bucala R
FASEB J; 2020 Mar; 34(3):4219-4233. PubMed ID: 31961019
[TBL] [Abstract][Full Text] [Related]
30. Macrophage migration inhibitory factor family proteins are multitasking cytokines in tissue injury.
Song S; Xiao Z; Dekker FJ; Poelarends GJ; Melgert BN
Cell Mol Life Sci; 2022 Jan; 79(2):105. PubMed ID: 35091838
[TBL] [Abstract][Full Text] [Related]
31. MIF and D-DT are potential disease severity modifiers in male MS subjects.
Benedek G; Meza-Romero R; Jordan K; Zhang Y; Nguyen H; Kent G; Li J; Siu E; Frazer J; Piecychna M; Du X; Sreih A; Leng L; Wiedrick J; Caillier SJ; Offner H; Oksenberg JR; Yadav V; Bourdette D; Bucala R; Vandenbark AA
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8421-E8429. PubMed ID: 28923927
[TBL] [Abstract][Full Text] [Related]
32. Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.
Mawhinney L; Armstrong ME; O' Reilly C; Bucala R; Leng L; Fingerle-Rowson G; Fayne D; Keane MP; Tynan A; Maher L; Cooke G; Lloyd D; Conroy H; Donnelly SC
Mol Med; 2015 Apr; 20(1):729-35. PubMed ID: 25826675
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of MIF leads to cell cycle arrest and apoptosis in pancreatic cancer cells.
Denz A; Pilarsky C; Muth D; Rückert F; Saeger HD; Grützmann R
J Surg Res; 2010 May; 160(1):29-34. PubMed ID: 19726058
[TBL] [Abstract][Full Text] [Related]
34. MIF confers survival advantage to pancreatic CAFs by suppressing interferon pathway-induced p53-dependent apoptosis.
Suresh V; Dash P; Suklabaidya S; Murmu KC; Sasmal PK; Jogdand GM; Parida D; Sethi M; Das B; Mohapatra D; Saha S; Prasad P; Satoskar A; Senapati S
FASEB J; 2022 Aug; 36(8):e22449. PubMed ID: 35839070
[TBL] [Abstract][Full Text] [Related]
35. Control of p53 and NF-κB signaling by WIP1 and MIF: role in cellular senescence and organismal aging.
Salminen A; Kaarniranta K
Cell Signal; 2011 May; 23(5):747-52. PubMed ID: 20940041
[TBL] [Abstract][Full Text] [Related]
36. P115 promotes growth of gastric cancer through interaction with macrophage migration inhibitory factor.
Li XJ; Luo Y; Yi YF
World J Gastroenterol; 2013 Dec; 19(46):8619-29. PubMed ID: 24379579
[TBL] [Abstract][Full Text] [Related]
37. Role of macrophage migration inhibitory factor in heat-induced apoptosis in keratinocytes.
Yoshihisa Y; Rehman MU; Kondo T; Shimizu T
FASEB J; 2016 Nov; 30(11):3870-3877. PubMed ID: 27528627
[TBL] [Abstract][Full Text] [Related]
38. D-dopachrome tautomerase in adipose tissue inflammation and wound repair.
Kim BS; Tilstam PV; Hwang SS; Simons D; Schulte W; Leng L; Sauler M; Ganse B; Averdunk L; Kopp R; Stoppe C; Bernhagen J; Pallua N; Bucala R
J Cell Mol Med; 2017 Jan; 21(1):35-45. PubMed ID: 27605340
[TBL] [Abstract][Full Text] [Related]
39. D-dopachrome tautomerase in cardiovascular and inflammatory diseases-A new kid on the block or just another MIF?
Zan C; Yang B; Brandhofer M; El Bounkari O; Bernhagen J
FASEB J; 2022 Nov; 36(11):e22601. PubMed ID: 36269019
[TBL] [Abstract][Full Text] [Related]
40. Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion.
Qi D; Hu X; Wu X; Merk M; Leng L; Bucala R; Young LH
J Clin Invest; 2009 Dec; 119(12):3807-16. PubMed ID: 19920350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
